Skip to main content
Publications
Fuller CC, Kawai AT, Haynes K, Coughlin K, Reynolds JS, Hawrusik R, Horgan C, Calingaert B, Johannes CB, Bradley Layton J, Peterson A, Praet N, Willame C, Yost E, Brannan C, McMahill-Walraven CNN, Guzman M, Jamal-allial A, Nair V, Seals RM, Wang FT, Selvan M, Ma Q, Platt R, Gilsenan AW, Brown J. Capacity for identifying Janssen Ad26.COV2.S COVID-19 vaccination in four US health insurance and state Immunization Information System databases: preparation for a post authorization safety study. Presented at the 2022 ICPE Conference; August 2022. Copenhagen, Denmark.
Bhatia S, Nghiem P, Veeranki SP, Vanegas A, Lachance K, Tachiki L, Chiu K, Boller E, Bharmal M. Real-world clinical outcomes among patients with advanced Merkel cell carcinoma treated with avelumab in academic medical centers in the United States. Presented at the 2022 2nd International Symposium on Merkel Cell Carcinoma; April 25, 2022. Seattle, WA. Previously presented at the SITC 2021 36th Anniversary Annual Meeting.
Sperber N, Dong O, Roberts M, Dexter P, Elsey A, Ginsburg G, Horowitz C, Johnson J, Levy K, Ong H, Peterson J, Pollin T, Rakhra-Burris TK, Ramos M, Skaar T, Orlando L. How does the eric typology apply to implementation of clinical decision support for genomic medicine?: specifying and reporting implementation strategies for desired outcomes among a genomic medicine implementation network. Presented at the 14th Annual Conference on the Science of Dissemination and Implementation in Health; December 15, 2021.
Walters MC, Tisdale JF, Mapara MY, Krishnamurti L, Kwiatkowski JL, Aygun B, Kasow KA, Rifkin-Zenenberg S, Jaroscak J, Garbinsky D, Chirila C, Gallagher ME, Zhang X, Ho PR, Thompson AA, Kanter J. Sustained improvements in patient-reported quality of life up to 24 months post-treatment with LentiGlobin for sickle cell disease (bb1111) gene therapy. Presented at the 2021 63rd American Society of Hematology (ASH) Annual Meeting & Exposition; December 11, 2021. Atlanta, Georgia. [abstract] Blood. 2021 Nov 23; 138(Suppl 1):7. doi: 10.1182/blood-2021-146905
Kelkar S, Corman S, Macahilig C, Prabhu V, Zhang J, Rusibamayila N, Odak S, Orlowski R, Duska L. Real-world patterns of care and outcomes in patients with microsatellite-instability high tumors in advanced endometrial cancer in the United States. Presented at the 22nd European Congress on Gynaecological Oncology (ESGO) 2021 Congress; October 24, 2021. Prague, Czech Republic.
Zhang Y, Johnson K, Yu Z, Fujimoto A, Lich KH, Ivy JS, Keskinocak P, Mayorga M, Swann J. The impact of interventions on COVID-19 transmission in K12 schools in fall 2021. Presented at the 2021 INFORMS Annual Meeting; October 24, 2021. Anaheim, CA.
Setoguchi S, Lai E, Gini R, Pajouheshnia R, Platt RW, Hall G, Kim J-H, Ilomaki J, Salinas CD. Methods to address heterogeneity in multi-database studies in pharmacoepidemiology: search for consensus and future directions. Presented at the ISPES 13th Asian Conference; October 15, 2021. Seoul, South Kroea.
Hoffman V, Hallas J, Linder M, Margulis AV, Suehs BT, Arana A, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S, Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD. Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: findings from a non-interventional, real-world data safety study. Presented at the Virtual ICPE 2021 Conference; August 24, 2021. Previously presented at the 2020 Virtual American Heart Association’s Scientific Sessions.